Pathophysiology, prophylaxis, and treatment of cardiac surgery-associated kidney injury. Position of the working group renal failure of the collaborative group Cardiothoracic Intensive Care of the DGAI and DGTHG on the consensus statement of the Acute Dialysis Quality Initiative;Pathophysiologie, Prophylaxe und Therapie von Herzchirurgie-assoziierten NierenfunktionsstöOudemans-vanrungen: Eine Stellungnahme der Arbeitsgruppe Niere des gemeinschaftlichen Arbeitskreises Intensivmedizin von DGAI und DGTHG unter Berücksichtigung der Konsensus-Empfehlungen der Acute Dialysis Quality Initiative

Zeitschrift fur Herz-, Thorax- und Gefasschirurgie

Volumn 23, Issue 6, 2009, Pages 1-23

  Heringlake, M ^a   Kindgen Milles, D ^b   Hackmann, F ^a   Haake, N ^c   Kielstein, J ^d   Lance, M ^e   Lufft, H ^f   Just, S ^g   Trabold, B ^h   Scherlitz, A ⁱ   Schirmer, U ^j   Schmitt, D ^k   Vargas Hein, O ^l   Markewitz, A ^m  

^a UNIVERSITY OF LÜBECK   (Germany)

^b UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

^c UNIVERSITY OF KIEL   (Germany)

^d HANNOVER MEDICAL SCHOOL   (Germany)

^e MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^f DEUTSCHES HERZZENTRUM BERLIN   (Germany)

^g Sana Herzzentrum Cottbus   (Germany)

^h UNIVERSITY OF REGENSBURG   (Germany)

ⁱ HELIOS KLINIKUM KREFELD   (Germany)

^j RUHR UNIVERSITY BOCHUM   (Germany)

^k Klinik fur Herzchirurgie   (Germany)

^l CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^m BUNDESWEHRZENTRALKRANKENHAUS KOBLENZ   (Germany)

more..

Author keywords

Acute kidney injury; Cardiac surgery; Chronic kidney disease

Indexed keywords

EID: 70350105452     PISSN: 09309225     EISSN: 14351277     Source Type: Journal    
DOI: None     Document Type: Article

References (200)

1. Bellomo R, Auriemma S, Fabbri A et al (2008) The pathophysiology of cardiac surgery-associated acute kidney injury (CSA-AKI). Int J Artif Organs 31: 166-178.
2. Schetz M, Bove T, Morelli A et al (2008) Prevention of cardiac surgery-associated acute kidney injury. Int J Artif Organs 31: 179-189.
3. Tolwani A, Paganini E, Joannidis M et al (2008) Treatment of patients with cardiac surgery associated-acute kidney injury. Int J Artif Organs 31: 190-196.
4. Hoste EA, Cruz DN, Davenport A et al (2008) The epidemiology of cardiac surgery-associated acute kidney injury. Int J Artif Organs 31: 158-165.
5. Ronco C, Kellum JA, Bellomo R (2008) Cardiac surgery-associated acute kidney injury. Int J Artif Organs 31: 156-157.
6. Mehta RL, Kellum JA, Shah SV et al (2007) Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care 11: R31.
7. Mangano CM, Diamondstone LS, Ramsay JG et al (1998) Renal dysfunction after myocardial revascularization: risk factors, adverse outcomes and hospital resource utilization. The Multicenter Study of Perioperative Ischemia Research Group. Ann Intern Med 128: 194-203.
8. Bundesgeschäftsstelle für Qualitätssicherung (BQS-online.org) Ergebnisse der Qualitätssicherung Herzchirurgie.
9. Heringlake M, Knappe M, Vargas-Hein O et al (2006) Renal dysfunction according to the ADQI-RIFLE system and clinical practice patterns after cardiac surgery in Germany. Minerva Anestesiol 72: 645-654.
10. Lassnigg A, Schmidlin D, Mouhieddine M et al (2004) Minimal changes of serum creatinine predict prognosis in patients after cardiothoracic surgery: a prospective cohort study. J Am Soc Nephrol 15: 1597-1605.
11. Lassnigg A, Schmid ER, Hiesmayr M et al (2008) Impact of minimal increases in serum creatinine on outcome in patients after cardiothoracic surgery: do we have to revise current definitions of acute renal failure? Crit Care Med 36: 1129-1137.
12. Stafford-Smith M, Patel UD, Phillips-Bute BG et al (2008) Acute kidney injury and chronic kidney disease after cardiac surgery. Adv Chronic Kidney Dis 15: 257-277.
13. Wijeysundera DN, Karkouti K, Beattie WS et al (2006) Improving the identification of patients at risk of postoperative renal failure after cardiac surgery. Anesthesiology 104: 65-72.
14. Cockcroft DW, Gault MH (1976) Prediction of creatinine clearance from serum creatinine. Nephron 16: 31-41.
15. Levey AS, Bosch JP, Lewis JB et al (1999) A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130: 461-470.
16. Brosius FC 3rd, Hostetter TH, Kelepouris E et al (2006) Detection of chronic kidney disease in patients with or at increased risk of cardiovascular disease: a science advisory from the American Heart Association Kidney And Cardiovascular Disease Council; the Councils on High Blood Pressure Research, Cardiovascular Disease in the Young and Epidemiology and Prevention; and the Quality of Care and Outcomes Research Interdisciplinary Working Group: developed in collaboration with the National Kidney Foundation. Circulation 114: 1083-1087.
17. Huerta-Alardin AL, Varon J, Marik PE (2005) Bench-to-bedside review: Rhabdomyolysis - an overview for clinicians. Crit Care 9: 158-169.
18. Holt S, Moore K (2000) Pathogenesis of renal failure in rhabdomyolysis: the role of myoglobin. Exp Nephrol 8: 72-76.
19. Moore KP, Holt SG, Patel RP et al (1998) A causative role for redox cycling of myoglobin and its inhibition by alkalinization in the pathogenesis and treatment of rhabdomyolysis-induced renal failure. J Biol Chem 273: 31731-31737.
20. Miller CC 3rd, Villa MA, Achouh P et al (2008) Intraoperative skeletal muscle ischemia contributes to risk of renal dysfunction following thoracoabdominal aortic repair. Eur J Cardiothorac Surg 33: 691-694.
21. Miller CC 3rd, Villa MA, Sutton J et al (2009) Serum myoglobin and renal morbidity and mortality following thoracic and thoraco-abdominal aortic repair: does rhabdomyolysis play a role? Eur J Vasc Endovasc Surg 37: 388-394.
22. De Freitas Carvalho DA, Valezi AC, De Brito EM et al (2006) Rhabdomyolysis after bariatric surgery. Obes Surg 16: 740-744.
23. Wigfield CH, Lindsey JD, Munoz A et al (2006) Is extreme obesity a risk factor for cardiac surgery? An analysis of patients with a BMI > or=40. Eur J Cardiothorac Surg 29: 434-440.
24. Hofmann D, Buettner M, Rissner F et al (2007) Prognostic value of serum myoglobin in patients after cardiac surgery. J Anesth 21: 304-310.
25. Vercaemst L (2008) Hemolysis in cardiac surgery patients undergoing cardiopulmonary bypass: a review in search of a treatment algorithm. J Extra Corpor Technol 40: 257-267.
26. Haase M, Haase-Fielitz A, Bagshaw SM et al (2007) Cardiopulmonary bypass-associated acute kidney injury: a pigment nephropathy? Contrib Nephrol 156: 340-353.
27. Haase M, Haase-Fielitz A, Bellomo R et al (2009) Sodium bicarbonate to prevent increases in serum creatinine after cardiac surgery: a pilot double-blind, randomized controlled trial. Crit Care Med 37: 39-47.
28. Pannu N, Nadim MK (2008) An overview of drug-induced acute kidney injury. Crit Care Med 36: S216-S223.
29. Benedetto U, Sciarretta S, Roscitano A et al (2008) Preoperative Angiotensin-converting enzyme inhibitors and acute kidney injury after coronary artery bypass grafting. Ann Thorac Surg 86: 1160-1165.
30. Arora P, Rajagopalam S, Ranjan R et al (2008) Preoperative use of angiotensin-converting enzyme inhibitors/angiotensin receptor blockers is associated with increased risk for acute kidney injury after cardiovascular surgery. Clin J Am Soc Nephrol 3: 1266-1273.
31. Ryckwaert F, Colson P, Ribstein J et al (2001) Haemodynamic and renal effects of intravenous enalaprilat during coronary artery bypass graft surgery in patients with ischaemic heart dysfunction. Br J Anaesth 86: 169-175.
32. Wagner F, Yeter R, Bisson S et al (2003) Beneficial hemodynamic and renal effects of intravenous enalaprilat following coronary artery bypass surgery complicated by left ventricular dysfunction. Crit Care Med 31: 1421-1428.
33. Ranucci M, Ballotta A, Kunkl A et al (2008) Influence of the timing of cardiac catheterization and the amount of contrast media on acute renal failure after cardiac surgery. Am J Cardiol 101: 1112-1118.
34. Mockel M, Radovic M, Kuhnle Y et al (2008) Acute renal haemodynamic effects of radiocontrast media in patients undergoing left ventricular and coronary angiography. Nephrol Dial Transplant 23: 1588-1594.
35. Heyman SN, Rosenberger C, Rosen S (2005) Regional alterations in renal haemodynamics and oxygenation: a role in contrast medium-induced nephropathy. Nephrol Dial Transplant 20(Suppl 1): i6-i11.
36. Dangas G, Lakovou L, Nikolsky E et al (2005) Contrast-induced nephropathy after percutaneous coronary interventions in relation to chronic kidney disease and hemodynamic variables. Am J Cardiol 95: 13-19.
37. Nikolsky E, Mehran R, Lasic Z et al (2005) Low hematocrit predicts contrast-induced nephropathy after percutaneous coronary interventions. Kidney Int 67: 706-713.
38. Carson JL, Scholz PM, Chen AY et al (2002) Diabetes mellitus increases short-term mortality and morbidity in patients undergoing coronary artery bypass graft surgery. J Am Coll Cardiol 40: 418-423.
39. Doddakula K, Al-Sarraf N, Gately K et al (2007) Predictors of acute renal failure requiring renal replacement therapy post cardiac surgery in patients with preoperatively normal renal function. Interact Cardiovasc Thorac Surg 6: 314-318.
40. Halkos ME, Puskas JD, Lattouf OM et al (2008) Elevated preoperative hemoglobin A1c level is predictive of adverse events after coronary artery bypass surgery. J Thorac Cardiovasc Surg 136: 631-640.
41. Ouattara A, Lecomte P, Le Manach Y et al (2005) Poor intraoperative blood glucose control is associated with a worsened hospital outcome after cardiac surgery in diabetic patients. Anesthesiology 103: 687-694.
42. Doenst T, Wijeysundera D, Karkouti K et al (2005) Hyperglycemia during cardiopulmonary bypass is an independent risk factor for mortality in patients undergoing cardiac surgery. J Thorac Cardiovasc Surg 130: 1144.
43. Ascione R, Rogers CA, Rajakaruna C et al (2008) Inadequate blood glucose control is associated with in-hospital mortality and morbidity in diabetic and nondiabetic patients undergoing cardiac surgery. Circulation 118: 113-123.
44. Esposito K, Nappo F, Marfella R et al (2002) Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress. Circulation 106: 2067-2072.
45. Ranucci M, De Toffol B, Isgro G et al (2006) Hyperlactatemia during cardiopulmonary bypass: determinants and impact on postoperative outcome. Crit Care 10: R167.
46. Heringlake M, Wernerus M, Grunefeld J et al (2007) The metabolic and renal effects of adrenaline and milrinone in patients with myocardial dysfunction after coronary artery bypass grafting. Crit Care 11: R51.
47. van Den Berghe G, Wouters P, Weekers F et al (2001) Intensive insulin therapy in the critically ill patients. N Engl J Med 345: 1359-1367.
48. Finfer S, Chittock DR, Su SY et al (2009) Intensive versus conventional glucose control in critically ill patients. N Engl J Med 360: 1283-1297.
49. Griesdale DE, De Souza RJ, van Dam RM et al (2009) Intensive insulin therapy and mortality among critically ill patients: a meta-analysis including NICE-SUGAR study data. CMAJ 180: 821-827.
50. Lecomte P, van Vlem B, Coddens J et al (2008) Tight perioperative glucose control is associated with a reduction in renal impairment and renal failure in non-diabetic cardiac surgical patients. Crit Care 12: R154.
51. Gandhi GY, Nuttall GA, Abel MD et al (2007) Intensive intraoperative insulin therapy versus conventional glucose management during cardiac surgery: a randomized trial. Ann Intern Med 146: 233-243.
52. Lipshutz AK, Gropper MA (2009) Perioperative glycemic control: an evidence-based review. Anesthesiology 110: 408-421.
53. Lecomte P, Foubert L, Nobels F et al (2008) Dynamic tight glycemic control during and after cardiac surgery is effective, feasible and safe. Anesth Analg 107: 51-58.
54. Legrand M, Mik EG, Johannes T et al (2008) Renal hypoxia and dysoxia after reperfusion of the ischemic kidney. Mol Med 14: 502-516.
55. Abuelo JG (2007) Normotensive ischemic acute renal failure. N Engl J Med 357: 797-805.
56. Urzua J, Troncoso S, Bugedo G et al (1992) Renal function and cardiopulmonary bypass: effect of perfusion pressure. J Cardiothorac Vasc Anesth 6: 299-303.
57. Fischer UM, Weissenberger WK, Warters RD et al (2002) Impact of cardiopulmonary bypass management on postcardiac surgery renal function. Perfusion 17: 401-406.
58. Shanmugam G (2005) Vasoplegic syndrome-the role of methylene blue. Eur J Cardiothorac Surg 28: 705-710.
59. Hobbhahn J, Habazettl H, Conzen P et al (1991) Complications caused by protamine. 1: Pharmacology and pathophysiology. Anaesthesist 40: 365-374.
60. Hobbhahn J, Habazettl H, Conzen P et al (1991) Complications caused by protamine. 2. Therapy and prevention. Anaesthesist 40: 421-428.
61. Brienza N, Giglio MT, Marucci M et al (2009) Does perioperative hemodynamic optimization protect renal function in surgical patients? A meta-analytic study. Crit Care Med 37: 2079-2090.
62. Kaczmarczyk G, Vogel S, Krebs M et al (1996) Vasopressin and renin-angiotensin maintain arterial pressure during PEEP in nonexpanded, conscious dogs. Am J Physiol 271: R1396-R1402.
63. Boldt J, Brenner T, Lehmann A et al (2003) Is kidney function altered by the duration of cardiopulmonary bypass? Ann Thorac Surg 75: 906-912.
64. Ranucci M, Romitti F, Isgro G et al (2005) Oxygen delivery during cardiopulmonary bypass and acute renal failure after coronary operations. Ann Thorac Surg 80: 2213-2220.
65. Valentine S, Barrowcliffe M, Peacock J (1993) A comparison of effects of fixed and tailored cardiopulmonary bypass flowrates on renal function. Anaesth Intensive Care 21: 304-308.
66. Fiore G, Brienza N, Cicala P et al (2006) Superior mesenteric artery blood flow modifications during off-pump coronary surgery. Ann Thorac Surg 82: 62-67.
67. Blauth CI, Cosgrove DM, Webb BW et al (1992) Atheroembolism from the ascending aorta. An emerging problem in cardiac surgery. J Thorac Cardiovasc Surg 103: 1104-1111; discussion 1111-1112.
68. Davila-Roman VG, Kouchoukos NT, Schechtman KB et al (1999) Atherosclerosis of the ascending aorta is a predictor of renal dysfunction after cardiac operations. J Thorac Cardiovasc Surg 117: 111-116.
69. Charytan DM, Marulkar S (2006) Relationship of aortic atherosclerosis to acute renal failure following cardiac surgery. J Nephrol 19: 628-633.
70. Scolari F, Ravani P, Pola A et al (2003) Predictors of renal and patient outcomes in atheroembolic renal disease: a prospective study. J Am Soc Nephrol 14: 1584-1590.
71. Scolari F, Tardanico R, Zani R et al (2000) Cholesterol crystal embolism: A recognizable cause of renal disease. Am J Kidney Dis 36: 1089-1109.
72. van Zaane B, Zuithoff NP, Reitsma JB et al (2008) Meta-analysis of the diagnostic accuracy of transesophageal echocardiography for assessment of atherosclerosis in the ascending aorta in patients undergoing cardiac surgery. Acta Anaesthesiol Scand 52: 1179-1187.
73. Shann KG, Likosky DS, Murkin JM et al (2006) An evidence-based review of the practice of cardiopulmonary bypass in adults: a focus on neurologic injury, glycemic control, hemodilution and the inflammatory response. J Thorac Cardiovasc Surg 132: 283-290.
74. Svenarud P, Persson M, van Der Linden J (2004) Effect of CO2 insufflation on the number and behavior of air microemboli in open-heart surgery: a randomized clinical trial. Circulation 109: 1127-1132.
75. Reston JT, Tregear SJ, Turkelson CM (2003) Meta-analysis of short-term and mid-term outcomes following off-pump coronary artery bypass grafting. Ann Thorac Surg 76: 1510-1515.
76. Cheng DC, Bainbridge D, Martin JE et al (2005) Does off-pump coronary artery bypass reduce mortality, morbidity, and resource utilization when compared with conventional coronary artery bypass? A meta-analysis of randomized trials. Anesthesiology 102: 188-203.
77. Panesar SS, Athanasiou T, Nair S et al (2006) Early outcomes in the elderly: a meta-analysis of 4921 patients undergoing coronary artery bypass grafting-comparison between off-pump and on-pump techniques. Heart 92: 1808-1816.
78. Wagener G, Gubitosa G, Wang S et al (2009) A comparison of urinary neutrophil gelatinase-associated lipocalin in patients undergoing on- versus off-pump coronary artery bypass graft surgery. J Cardiothorac Vasc Anesth 23: 195-199.
79. Devarajan P (2006) Update on mechanisms of ischemic acute kidney injury. J Am Soc Nephrol 17: 1503-1520.
80. Nigwekar SU, Kandula P (2009) N-acetylcysteine in cardiovascular-surgery-associated renal failure: a meta-analysis. Ann Thorac Surg 87: 139-147.
81. Ho KM, Morgan DJ (2009) Meta-analysis of N-acetylcysteine to prevent acute renal failure after major surgery. Am J Kidney Dis 53: 33-40.
82. Naughton F, Wijeysundera D, Karkouti K et al (2008) N-acetylcysteine to reduce renal failure after cardiac surgery: a systematic review and meta-analysis. Can J Anaesth 55: 827-835.
83. Tanaka K, Weihrauch D, Kehl F et al (2002) Mechanism of preconditioning by isoflurane in rabbits: a direct role for reactive oxygen species. Anesthesiology 97: 1485-1490.
84. Wijeysundera DN, Karkouti K, Rao V et al (2009) N-acetylcysteine is associated with increased blood loss and blood product utilization during cardiac surgery. Crit Care Med 37: 1929-1934.
85. Landoni G, Biondi-Zoccai GG, Zangrillo A et al (2007) Desflurane and sevoflurane in cardiac surgery: a meta-analysis of randomized clinical trials. J Cardiothorac Vasc Anesth 21: 502-511.
86. Lee HT, Kim M, Kim N et al (2007) Isoflurane protects against renal ischemia and reperfusion injury and modulates leukocyte infiltration in mice. Am J Physiol Renal Physiol 293: F713-F722.
87. Lee HT, Ota-Setlik A, Fu Y et al (2004) Differential protective effects of volatile anesthetics against renal ischemia-reperfusion injury in vivo. Anesthesiology 101: 1313-1324.
88. Julier K, Da Silva R, Garcia C et al (2003) Preconditioning by sevoflurane decreases biochemical markers for myocardial and renal dysfunction in coronary artery bypass graft surgery: a double-blinded, placebo-controlled, multicenter study. Anesthesiology 98: 1315-1327.
89. Heringlake M (2002) Cardio-renal-axis-physiology, pathophysiology and clinical relevance? Anasthesiol Intensivmed Notfallmed Schmerzther 37: 250-257.
90. Riddez L, Hahn RG, Brismar B et al (1997) Central and regional hemodynamics during acute hypovolemia and volume substitution in volunteers. Crit Care Med 25: 635-640.
91. Hynynen M, Salmenpera M, Harjula AI et al (1990) Atrial pressure and hormonal and renal responses to acute cardiac tamponade. Ann Thorac Surg 49: 632-637.
92. Clerico A, Recchia FA, Passino C et al (2006) Cardiac endocrine function is an essential component of the homeostatic regulation network: physiological and clinical implications. Am J Physiol Heart Circ Physiol 290: H17-H29.
93. McGuinness J, Bouchier-Hayes D, Redmond JM (2008) Understanding the inflammatory response to cardiac surgery. Surgeon 6: 162-171.
94. McBride WT (2007) Mediators of inflammation at cardiac surgery. Appl Cardiopulm Pathophysiol 11: 4-22.
95. Heymans S, Hirsch E, Anker SD et al (2009) Inflammation as a therapeutic target in heart failure? A scientific statement from the Translational Research Committee of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail 11: 119-129.
96. Deng MC, Dasch B, Erren M et al (1996) Impact of left ventricular dysfunction on cytokines, hemodynamics and outcome in bypass grafting. Ann Thorac Surg 62: 184-190.
97. Baker RC, Armstrong MA, Allen SJ et al (2002) Role of the kidney in perioperative inflammatory responses. Br J Anaesth 88: 330-334.
98. Tripepi G, Mallamaci F, Zoccali C (2005) Inflammation markers, adhesion molecules and all-cause and cardiovascular mortality in patients with ESRD: searching for the best risk marker by multivariate modeling. J Am Soc Nephrol 16(Suppl 1): S83-S88.
99. Wan L, Bagshaw SM, Langenberg C et al (2008) Pathophysiology of septic acute kidney injury: what do we really know? Crit Care Med 36: S198-S203.
100. Wang W, Zolty E, Falk S et al (2006) Pentoxifylline protects against endotoxin-induced acute renal failure in mice. Am J Physiol Renal Physiol 291: F1090-F1095.
101. Liakopoulos OJ, Choi YH, Haldenwang PL et al (2008) Impact of preoperative statin therapy on adverse postoperative outcomes in patients undergoing cardiac surgery: a meta-analysis of over 30, 000 patients. Eur Heart J 29: 1548-1559.
102. Huffmyer JL, Mauermann WJ, Thiele RH et al (2009) Preoperative statin administration is associated with lower mortality and decreased need for postoperative hemodialysis in patients undergoing coronary artery bypass graft surgery. J Cardiothorac Vasc Anesth 23: 468-473.
103. Fedoruk LM, Wang H, Conaway MR et al (2008) Statin therapy improves outcomes after valvular heart surgery. Ann Thorac Surg 85: 1521-1525.
104. Tang AT, Alexiou C, Hsu J et al (2002) Leukodepletion reduces renal injury in coronary revascularization: a prospective randomized study. Ann Thorac Surg 74: 372-377.
105. Boldt J, Brosch C, Lehmann A et al (2004) The prophylactic use of the beta-blocker esmolol in combination with phosphodiesterase III inhibitor enoximone in elderly cardiac surgery patients. Anesth Analg 99: 1009-1017.
106. Boldt J, Brosch C, Piper SN et al (2001) Influence of prophylactic use of pentoxifylline on postoperative organ function in elderly cardiac surgery patients. Crit Care Med 29: 952-958.
107. Sandek A, Rauchhaus M, Anker SD et al (2008) The emerging role of the gut in chronic heart failure. Curr Opin Clin Nutr Metab Care 11: 632-639.
108. Geppert A, Huber K (2004) Inflammation and cardiovascular diseases: lessons that can be learned for the patient with cardiogenic shock in the intensive care unit. Curr Opin Crit Care 10: 347-353.
109. Geppert A, Dorninger A, Delle-Karth G et al (2006) Plasma concentrations of interleukin-6, organ failure, vasopressor support and successful coronary revascularization in predicting 30-day mortality of patients with cardiogenic shock complicating acute myocardial infarction. Crit Care Med 34: 2035-2042.
110. Lenz A, Franklin GA, Cheadle WG (2007) Systemic inflammation after trauma. Injury 38: 1336-1345.
111. Kinugawa T, Kato M, Ogino K et al (2003) Interleukin-6 and tumor necrosis factor-alpha levels increase in response to maximal exercise in patients with chronic heart failure. Int J Cardiol 87: 83-90.
112. Matsuoka T (1990) A sedative effect of dopamine on the respiratory burst in neonatal polymorphonuclear leukocytes. Pediatr Res 28: 24-27.
113. Sookhai S, Wang JH, Winter D et al (2000) Dopamine attenuates the chemoattractant effect of interleukin-8: a novel role in the systemic inflammatory response syndrome. Shock 14: 295-299.
114. Boldt J, Brosch C, Suttner S et al (2002) Prophylactic use of the phospodiesterase III inhibitor enoximone in elderly cardiac surgery patients: effect on hemodynamics, inflammation and markers of organ function. Intensive Care Med 28: 1462-1469.
115. Fabre O, Vincentelli A, Corseaux D et al (2008) Comparison of blood activation in the wound, active vent and cardiopulmonary bypass circuit. Ann Thorac Surg 86: 537-541.
116. Marcheix B, Carrier M, Martel C et al (2008) Effect of pericardial blood processing on postoperative inflammation and the complement pathways. Ann Thorac Surg 85: 530-535.
117. Carl M, Alms A, Braun J et al (2007) Guidelines for intensive care in cardiac surgery patients: haemodynamic monitoring and cardio-circulatory treatment guidelines of the German Society for Thoracic and Cardiovascular Surgery and the German Society of Anaesthesiology and Intensive Care Medicine. Thorac Cardiovasc Surg 55: 130-148.
118. Sumeray M, Robertson C, Lapsley M et al (2001) Low dose dopamine infusion reduces renal tubular injury following cardiopulmonary bypass surgery. J Nephrol 14: 397-402.
119. Yavuz S, Ayabakan N, Goncu MT et al (2002) Effect of combined dopamine and diltiazem on renal function after cardiac surgery. Med Sci Monit 8:PI45-PI50
120. Woo EB, Tang AT, El-Gamel A et al (2002) Dopamine therapy for patients at risk of renal dysfunction following cardiac surgery: science or fiction? Eur J Cardiothorac Surg 22: 106-111.
121. Myles PS, Buckland MR, Schenk NJ et al (1993) Effect of "renal-dose" dopamine on renal function following cardiac surgery. Anaesth Intensive Care 21: 56-61.
122. Friedrich JO, Adhikari N, Herridge MS et al (2005) Meta-analysis: low-dose dopamine increases urine output but does not prevent renal dysfunction or death. Ann Intern Med 142: 510-524.
123. Ranucci M, Soro G, Barzaghi N et al (2004) Fenoldopam prophylaxis of postoperative acute renal failure in high-risk cardiac surgery patients. Ann Thorac Surg 78: 1332-1337.
124. Caimmi PP, Pagani L, Micalizzi E et al (2003) Fenoldopam for renal protection in patients undergoing cardiopulmonary bypass. J Cardiothorac Vasc Anesth 17: 491-494.
125. Cogliati AA, Vellutini R, Nardini A et al (2007) Fenoldopam infusion for renal protection in high-risk cardiac surgery patients: a randomized clinical study. J Cardiothorac Vasc Anesth 21: 847-850.
126. Bove T, Landoni G, Calabro MG et al (2005) Renoprotective action of fenoldopam in high-risk patients undergoing cardiac surgery: a prospective, double-blind, randomized clinical trial. Circulation 111: 3230-3235.
127. Landoni G, Biondi-Zoccai GG, Marino G et al (2008) Fenoldopam reduces the need for renal replacement therapy and in-hospital death in cardiovascular surgery: a meta-analysis. J Cardiothorac Vasc Anesth 22: 27-33.
128. Lassnigg A, Donner E, Grubhofer G et al (2000) Lack of renoprotective effects of dopamine and furosemide during cardiac surgery. J Am Soc Nephrol 11: 97-104.
129. Lombardi R, Ferreiro A, Servetto C (2003) Renal function after cardiac surgery: adverse effect of furosemide. Ren Fail 25: 775-786.
130. Mahesh B, Yim B, Robson D et al (2008) Does furosemide prevent renal dysfunction in high-risk cardiac surgical patients? Results of a double-blinded prospective randomised trial. Eur J Cardiothorac Surg 33: 370-376.
131. Sezai A, Shiono M, Orime Y et al (2000) Low-dose continuous infusion of human atrial natriuretic peptide during and after cardiac surgery. Ann Thorac Surg 69: 732-738.
132. Hummel M, Kuhn M, Bub A et al (1992) Urodilatin: a new peptide with beneficial effects in the postoperative therapy of cardiac transplant recipients. Clin Invest 70: 674-682.
133. Hummel M, Kuhn M, Bub A et al (1993) Urodilatin, a new therapy to prevent kidney failure after heart transplantation. J Heart Lung Transplant 12: 209-217.
134. Mentzer RM Jr, Oz MC, Sladen RN et al (2007) Effects of perioperative nesiritide in patients with left ventricular dysfunction undergoing cardiac surgery: the NAPA Trial. J Am Coll Cardiol 49: 716-726.
135. Chen HH, Sundt TM, Cook DJ et al (2007) Low dose nesiritide and the preservation of renal function in patients with renal dysfunction undergoing cardiopulmonary-bypass surgery: a double-blind placebo-controlled pilot study. Circulation 116: I134-I138.
136. Aaronson KD, Sackner-Bernstein J (2006) Risk of death associated with nesiritide in patients with acutely decompensated heart failure. JAMA 296: 1465-1466.
137. Sackner-Bernstein JD, Skopicki HA, Aaronson KD (2005) Risk of worsening renal function with nesiritide in patients with acutely decompensated heart failure. Circulation 111: 1487-1491.
138. Yallop KG, Sheppard SV, Smith DC (2008) The effect of mannitol on renal function following cardio-pulmonary bypass in patients with normal pre-operative creatinine. Anaesthesia 63: 576-582.
139. Smith MN, Best D, Sheppard SV et al (2008) The effect of mannitol on renal function after cardiopulmonary bypass in patients with established renal dysfunction. Anaesthesia 63: 701-704.
140. Kaya K, Oguz M, Akar AR et al (2007) The effect of sodium nitroprusside infusion on renal function during reperfusion period in patients undergoing coronary artery bypass grafting: a prospective randomized clinical trial. Eur J Cardiothorac Surg 31: 290-297.
141. Kramer BK, Preuner J, Ebenburger A et al (2002) Lack of renoprotective effect of theophylline during aortocoronary bypass surgery. Nephrol Dial Transplant 17: 910-915.
142. McBride WT, Allen S, Gormley SM et al (2004) Methylprednisolone favourably alters plasma and urinary cytokine homeostasis and subclinical renal injury at cardiac surgery. Cytokine 27: 81-89.
143. Kulka PJ, Tryba M, Zenz M (1996) Preoperative alpha2-adrenergic receptor agonists prevent the deterioration of renal function after cardiac surgery: results of a randomized, controlled trial. Crit Care Med 24: 947-952.
144. Parikh CR, Devarajan P (2008) New biomarkers of acute kidney injury. Crit Care Med 36: S159-S165.
145. Kellum JA, Decker M (2001) Use of dopamine in acute renal failure: a meta-analysis. Crit Care Med 29: 1526-1531.
146. Bellomo R, Chapman M, Finfer S et al (2000) Low-dose dopamine in patients with early renal dysfunction: a placebo-controlled randomised trial. Australian and New Zealand Intensive Care Society (ANZICS) Clinical Trials Group. Lancet 356: 2139-2143.
147. Lauschke A, Teichgraber UK, Frei U et al (2006) Low-dose dopamine worsens renal perfusion in patients with acute renal failure. Kidney Int 69: 1669-1674.
148. Tumlin JA, Finkel KW, Murray PT et al (2005) Fenoldopam mesylate in early acute tubular necrosis: a randomized, double-blind, placebo-controlled clinical trial. Am J Kidney Dis 46: 26-34.
149. Brienza N, Malcangi V, Dalfino L et al (2006) A comparison between fenoldopam and low-dose dopamine in early renal dysfunction of critically ill patients. Crit Care Med 34: 707-714.
150. Anderson RJ, Linas SI, Berns AS et al (1977) Nonoliguric acute renal failure. N Engl J Med 296: 1134-1138.
151. Bagshaw SM, Delaney A, Haase M et al (2007) Loop diuretics in the management of acute renal failure: a systematic review and meta-analysis. Crit Care Resusc 9: 60-68.
152. Kleinknecht D, Ganeval D, Gonzalez-Duque LA et al (1976) Furosemide in acute oliguric renal failure. A controlled trial. Nephron 17: 51-58.
153. Mehta RL, Pascual MT, Soroko S et al (2002) Diuretics, mortality and nonrecovery of renal function in acute renal failure. JAMA 288: 2547-2553.
154. Hasselblad V, Gattis Stough W, Shah MR et al (2007) Relation between dose of loop diuretics and outcomes in a heart failure population: results of the ESCAPE trial. Eur J Heart Fail 9: 1064-1069.
155. Karajala V, Mansour W, Kellum JA (2009) Diuretics in acute kidney injury. Minerva Anestesiol 75: 251-257.
156. Sirivella S, Gielchinsky I, Parsonnet V (2000) Mannitol, furosemide and dopamine infusion in postoperative renal failure complicating cardiac surgery. Ann Thorac Surg 69: 501-506.
157. Visweswaran P, Massin EK, Dubose TD Jr (1997) Mannitol-induced acute renal failure. J Am Soc Nephrol 8: 1028-1033.
158. Allgren RL, Marbury TC, Rahman SN et al (1997) Anaritide in acute tubular necrosis. Auriculin Anaritide Acute Renal Failure Study Group. N Engl J Med 336: 828-834.
159. Lewis J, Salem MM, Chertow GM et al (2000) Atrial natriuretic factor in oliguric acute renal failure. Anaritide Acute Renal Failure Study Group. Am J Kidney Dis 36: 767-774.
160. Sward K, Valsson F, Odencrants P et al (2004) Recombinant human atrial natriuretic peptide in ischemic acute renal failure: a randomized placebo-controlled trial. Crit Care Med 32: 1310-1315.
161. Beaver TM, Winterstein AG, Shuster JJ et al (2006) Effectiveness of nesiritide on dialysis or all-cause mortality in patients undergoing cardiothoracic surgery. Clin Cardiol 29: 18-24.
162. Chow SL, Peng JT, Okamoto MP et al (2007) Effect of nesiritide infusion duration on renal function in acutely decompensated heart failure patients. Ann Pharmacother 41: 556-561.
163. Witteles RM, Kao D, Christopherson D et al (2007) Impact of nesiritide on renal function in patients with acute decompensated heart failure and pre-existing renal dysfunction a randomized, double-blind, placebo-controlled clinical trial. J Am Coll Cardiol 50: 1835-1840.
164. Wiebe K, Meyer M, Wahlers T et al (1996) Acute renal failure following cardiac surgery is reverted by administration of Urodilatin (INN: Ularitide). Eur J Med Res 1: 259-265.
165. Meyer M, Pfarr E, Schirmer G et al (1999) Therapeutic use of the natriuretic peptide ularitide in acute renal failure. Ren Fail 21: 85-100.
166. Hoffmann H, Markewitz A, Kreuzer E et al (1998) Pentoxifylline decreases the incidence of multiple organ failure in patients after major cardio-thoracic surgery. Shock 9: 235-240.
167. Vesey DA, Cheung C, Pat B et al (2004) Erythropoietin protects against ischaemic acute renal injury. Nephrol Dial Transplant 19: 348-355.
168. Gibney N, Hoste E, Burdmann EA et al (2008) Timing of initiation and discontinuation of renal replacement therapy in AKI: unanswered key questions. Clin J Am Soc Nephrol 3: 876-880.
169. Meyer TW, Hostetter TH (2007) Uremia. N Engl J Med 357: 1316-1325.
170. Palevsky PM (2008) Indications and timing of renal replacement therapy in acute kidney injury. Crit Care Med 36: S224-S228.
171. Bellomo R, Ronco C, Kellum JA et al (2004) Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 8: R204-R212.
172. Seabra VF, Balk EM, Liangos O et al (2008) Timing of renal replacement therapy initiation in acute renal failure: a meta-analysis. Am J Kidney Dis 52: 272-284.
173. Durmaz I, Yagdi T, Calkavur T et al (2003) Prophylactic dialysis in patients with renal dysfunction undergoing on-pump coronary artery bypass surgery. Ann Thorac Surg 75: 859-864.
174. Bouman CS, Oudemans-van Straaten HM, Tijssen JG et al (2002) Effects of early high-volume continuous venovenous hemofiltration on survival and recovery of renal function in intensive care patients with acute renal failure: a prospective, randomized trial. Crit Care Med 30: 2205-2211.
175. Demirkilic U, Kuralay E, Yenicesu M et al (2004) Timing of replacement therapy for acute renal failure after cardiac surgery. J Card Surg 19: 17-20.
176. Ronco C, Ricci Z (2008) Renal replacement therapies: physiological review. Intensive Care Med 34: 2139-2146.
177. Forni LG, Hilton PJ (1997) Continuous hemofiltration in the treatment of acute renal failure. N Engl J Med 336: 1303-1309.
178. Berbece AN, Richardson RM (2006) Sustained low-efficiency dialysis in the ICU: cost, anticoagulation and solute removal. Kidney Int 70: 963-968.
179. Kielstein JT, Hafer C (2006) Extended dialysis in intensive care: Korff dialysis rediscovered. Nephrologe 70: 963-968.
180. Rabindranath K, Adams J, Macleod AM et al (2007) Intermittent versus continuous renal replacement therapy for acute renal failure in adults. Cochrane Database Syst Rev:CD003773
181. Bagshaw SM, Berthiaume LR, Delaney A et al (2008) Continuous versus intermittent renal replacement therapy for critically ill patients with acute kidney injury: a meta-analysis. Crit Care Med 36: 610-617.
182. Lameire N, van Biesen W, Vanholder R (2005) Acute renal failure. Lancet 365: 417-430.
183. Paganini EP, Kanagasundaram NS, Larive B et al (2001) Prescription of adequate renal replacement in critically ill patients. Blood Purif 19: 238-244.
184. KDOQI (2006) Clinical practice guidelines and clinical practice recommendations for anemia in chronic kidney disease. Am J Kidney Dis 47: S11-S145.
185. Eloot S, van Biesen W, Dhondt A et al (2008) Impact of hemodialysis duration on the removal of uremic retention solutes. Kidney Int 73: 765-770.
186. Ronco C (2006) Recent evolution of renal replacement therapy in the critically ill patient. Crit Care 10: 123.
187. Conger JD (1975) A controlled evaluation of prophylactic dialysis in post-traumatic acute renal failure. J Trauma 15: 1056-1063.
188. Schiffl H, Lang SM, Fischer R (2002) Daily hemodialysis and the outcome of acute renal failure. N Engl J Med 346: 305-310.
189. Ronco C, Bellomo R, Homel P et al (2000) Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: a prospective randomised trial. Lancet 356: 26-30.
190. Saudan P, Niederberger M, De Seigneux S et al (2006) Adding a dialysis dose to continuous hemofiltration increases survival in patients with acute renal failure. Kidney Int 70: 1312-1317.
191. Tolwani AJ, Campbell RC, Stofan BS et al (2008) Standard versus high-dose CVVHDF for ICU-related acute renal failure. J Am Soc Nephrol 19: 1233-1238.
192. Palevsky PM, Zhang JH, O'Connor TZ et al (2008) Intensity of renal support in critically ill patients with acute kidney injury. N Engl J Med 359: 7-20.
193. Faulhaber-Walter R, Hafer C, Jahr N et al (2009) The Hannover Dialysis Outcome study: comparison of standard versus intensified extended dialysis for treatment of patients with acute kidney injury in the intensive care unit. Nephrol Dial Transplant 24: 2179-2186.
194. Kielstein JT (2009) Dosis der Nierenersatztherapie bei akutem Nierenversagen. Dtsch Med Wochenschr 134: 1-3.
195. Honore PM, Jamez J, Wauthier M et al (2000) Prospective evaluation of short-term, high-volume isovolemic hemofiltration on the hemodynamic course and outcome in patients with intractable circulatory failure resulting from septic shock. Crit Care Med 28: 3581-3587.
196. Vesconi S, Cruz DN, Fumagalli R et al (2009) Delivered dose of renal replacement therapy and mortality in critically ill patients with acute kidney injury. Crit Care 13: R57.
197. Chertow GM, Levy EM, Hammermeister KE et al (1998) Independent association between acute renal failure and mortality following cardiac surgery. Am J Med 104: 343-348.
198. Hamada Y, Kawachi K, Tsunooka N et al (2004) Capillary leakage in cardiac surgery with cardiopulmonary bypass. Asian Cardiovasc Thorac Ann 12: 193-197.
199. Loeffelbein F, Zirell U, Benk C et al (2008) High colloid oncotic pressure priming of cardiopulmonary bypass in neonates and infants: implications on haemofiltration, weight gain and renal function. Eur J Cardiothorac Surg 34: 648-652.
200. Martin FL, Chen HH, Cataliotti A et al (2008) Targeting the kidney in acute decompensated heart failure: conventional diuretics and renal-acting vasodilators. Rev Cardiovasc Med 9: 39-45.